Dr. Michael S. Lee, MD
- Medicare services, 2023
- 237
- Part D claims, 2023
- 75
- Publications
- 30
- Clinical trials
- 4
- MIPS score, 2024
- 84
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lee's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael S. Lee is a hematologist and oncologist in Houston, Texas
Dr. Lee practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Lee's NPI, 1952539108, was assigned on June 26, 2009. Dr. Lee graduated from Duke University School Of Medicine in 2009. Dr. Lee holds Texas license S5966.
- NPI
- 1952539108NPI Registry (opens in a new tab)
- NPI enumeration date
- June 26, 2009
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 43
- Medical school graduation
- 2009
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Michael S. Lee practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Lee's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Source: Dmand AI Affiliation Data
Dr. Michael S. Lee is affiliated with 1 site of care
Dr. Lee's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael S. Lee's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael S. Lee is one of 814 hematologists and oncologists in Texas
Hematology and oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lee is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 11 states: Texas, Florida, Arizona, Tennessee, Washington, Georgia, Louisiana, Mississippi, Oklahoma, Alabama and North Carolina.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
- Florida license
- Arizona license
- Tennessee license
- Washington license
- Georgia license
- Louisiana license
- Mississippi license
- Oklahoma license
- Alabama license
- North Carolina license
Clinical focus
Dmand AI lists colorectal cancer, fluid and electrolyte imbalances and prostate cancer among the conditions Dr. Lee treats.
Hematologists and oncologists near Dr. Lee
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael S. Lee billed Medicare for 237 services in 2023
CMS data shows 237 Medicare services from Dr. Lee across 4 procedure codes in 2023, all of them office visits. Medicare paid $23,353 for them.
Dr. Lee's Medicare services by type, 2022 to 2023
- 2022
- 2023
- Office and hospital visits
- 2022: 2962023: 23720%
Where Dr. Lee's Medicare services took place, 2023
- In an office6226%
- In a facility17574%
Dr. Lee compared with the Texas median for hematologists and oncologists, 2023
- Dr. Lee
- Texas median
- Medicare services
- 237vs 1,16280% below
- Part D claims
- 75vs 48985% below
Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.
Dr. Lee's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lee?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lee and other hematologists and oncologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Michael S. Lee's patients have a median age of 45
Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 45, with 50% women.
Dr. Lee's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 45
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Dr. Michael S. Lee wrote 75 Medicare Part D claims in 2023
In 2023, Dr. Lee wrote 75 Medicare Part D claims. They cover 4 drugs, with $31,120 in total drug cost. In 2022, CMS named 126 claims across 5 drugs.
Dr. Lee's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 1262023: 7540%
Drugs named by CMS: 4 in 2023, 5 in 2022.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
Dr. Michael S. Lee scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Lee for performance year 2024, reported as part of a group.
Dr. Lee's MIPS scores, performance year 2024
- 84of 100Final score
- 70.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 68of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael S. Lee has 30 publications on record
Dmand AI links 30 papers to Dr. Lee, published from 2013 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Biomarkers, Tumor. Dr. Lee has published most often in Oncologist. Dr. Lee's most frequent co-authors are Michael J. Overman, MD, Shubham Pant, MD and Hanna K. Sanoff, MD.
Dr. Lee's papers by year, 2013 to 2025
Topics Dr. Lee writes about most
- Colorectal Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor
- DNA Methylation
- Microsatellite Instability
- Camptothecin
- CpG Islands
- Genomics
Dr. Lee's most frequent co-authors
- Michael J. Overman, MD5 shared papers
- Shubham Pant, MD5 shared papers
- Hanna K. Sanoff, MD5 shared papers
Recent publications by Dr. Lee
See who Dr. Lee researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lee works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael S. Lee has worked on 4 clinical trials
Dmand AI links Dr. Lee to 4 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Colonic Neoplasms, Colorectal Neoplasms and Adenocarcinoma Of Esophagus. UNC Lineberger Comprehensive Cancer Center sponsors the most, 2. Open Payments lists research payments to Dr. Lee that name 1 trial.
Conditions in Dr. Lee's trials
- Colonic Neoplasms
- Colorectal Neoplasms
- Adenocarcinoma Of Esophagus
- Neoplasms, Squamous Cell
- Neoplasm Metastasis
Investigators on the most trials with Dr. Lee
- Autumn Jackson McRee, MD3 shared trials
- Cheryl A. Carlson, MD2 shared trials
- Mehmet Akce, MD1 shared trial
Recent clinical trials with Dr. Lee
Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas (opens in a new tab)
Palbociclib and Cetuximab in Metastatic Colorectal Cancer (opens in a new tab)
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael S. Lee received $45,374 in industry payments from 2016 to 2023
CMS Open Payments shows 64 general payments to Dr. Lee from 11 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 35% of the total. Genentech, Inc. paid the most, $32,576. It also lists 8 research payments totaling $10,875 from 2020 to 2021, naming 1 clinical trial.
General payments to Dr. Lee by program year, 2016 to 2023
General payments to Dr. Lee by kind, 2016 to 2023
- Speaker and faculty fees$15,75635%
- Travel and lodging$13,95531%
- Consulting fees$11,14425%
- Food and beverage$2,5206%
- Honoraria$2,0004%
Companies that paid Dr. Lee the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael S. Lee graduated from Duke University School Of Medicine
Dr. Lee graduated from Duke University School Of Medicine in 2009.
- Medical school
- Board certified in hematology
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Michael S. Lee accepts plans from 5 insurance carriers
Dr. Lee is in network with 5 carriers, including Excellus BlueCross BlueShield, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.
- Excellus BlueCross BlueShield
- Elevance
- Blue Cross Blue Shield of Michigan
- Blue Cross Blue Shield of Massachusetts
- Arkansas Blue Cross and Blue Shield
Plan types Dr. Lee accepts, by number of carriers
- PPO5
- Medicare4
- POS3
- EPO2
- HMO1
Source: Dmand AI Insurance Network Data
Sources for Dr. Michael S. Lee's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael S. Lee
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael S. Lee's NPI number?
Dr. Michael S. Lee's NPI number is 1952539108. It was assigned on June 26, 2009, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael S. Lee?
Dr. Michael S. Lee is a hematologist and oncologist in Houston, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Michael S. Lee practice?
Dr. Lee practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Lee's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
What is Dr. Michael S. Lee's medical license number?
Dr. Lee holds Texas license S5966, one of the licenses on file in 11 states.
Which states has Dr. Michael S. Lee been licensed in?
Dmand AI has state licenses on file for Dr. Lee in Texas (2020 to 2026), Florida (since 2021), Arizona (2023 to 2025), Tennessee (2023 to 2025), Washington (2023 to 2025), Georgia (2023 to 2024), Louisiana (2023 to 2024), Mississippi (2023 to 2024), Oklahoma (2023 to 2024), Alabama (2023) and North Carolina (2015 to 2021).
Which hospitals is Dr. Michael S. Lee affiliated with?
Dr. Lee practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
Does Dr. Michael S. Lee accept Medicare?
Yes. CMS data shows Dr. Lee billed Medicare for 237 services in 2023.
What is Dr. Michael S. Lee's MIPS score?
Dr. Lee's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
Is Dr. Michael S. Lee board certified?
Yes. Dr. Lee is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Michael S. Lee bill to Medicare?
In 2023, Dr. Lee's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and office visit, new patient (99205).
Show 7 more questionsShow fewer questions
Where did Dr. Michael S. Lee go to medical school?
Dr. Lee graduated from Duke University School Of Medicine in 2009.
What drugs does Dr. Michael S. Lee prescribe most?
In 2023 Medicare Part D data, Dr. Lee's most prescribed drugs by claims were Eliquis, Prochlorperazine Maleate and Creon.
Has Dr. Michael S. Lee received payments from drug or device companies?
CMS Open Payments shows $45,374 in general payments to Dr. Lee from 11 companies from 2016 to 2023. The largest total came from Genentech, Inc.
How long has Dr. Michael S. Lee been practicing?
Dr. Lee graduated from medical school in 2009, 17 years ago.
Does Dr. Michael S. Lee do research?
Dmand AI links 30 publications to Dr. Lee, published from 2013 to 2025. Dr. Lee has worked on 4 clinical trials.
Who does Dr. Michael S. Lee publish with?
Dr. Lee's most frequent co-authors are Michael J. Overman, MD (5 shared papers), Shubham Pant, MD (5 shared papers) and Hanna K. Sanoff, MD (5 shared papers).
What insurance does Dr. Michael S. Lee accept?
Dr. Lee is in network with 5 carriers, including Excellus BlueCross BlueShield, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card